These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 22476860)
1. Conservative management of post-transplant central nervous system lymphoma. Valavoor SH; Ashraf Z; Narwal R; Ratnam S Int Urol Nephrol; 2013 Aug; 45(4):1219-22. PubMed ID: 22476860 [TBL] [Abstract][Full Text] [Related]
2. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus? Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy. Said-Conti V; Amrolia PJ; Gaze MN; Stoneham S; Sebire N; Shroff R; Marks SD Pediatr Nephrol; 2013 Oct; 28(10):2053-6. PubMed ID: 23743853 [TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report. Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782 [TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type. Ergisi M; Ooi B; Salim O; Papalois V Transplant Rev (Orlando); 2024 Apr; 38(2):100837. PubMed ID: 38430887 [TBL] [Abstract][Full Text] [Related]
6. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature. Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810 [TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience. Wasson S; Zafar MN; Best J; Reddy HK J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222 [TBL] [Abstract][Full Text] [Related]
8. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725 [TBL] [Abstract][Full Text] [Related]
10. Outcome of Brain Lymphoma in a High Epstein-Barr Virus-Prevalence Country After Kidney Transplantation. Huang YA; Wen MC; Tsai SF; Wu MJ; Yu TM; Chuang YW; Huang ST; Chen CH Transplant Proc; 2023 May; 55(4):858-861. PubMed ID: 37105830 [TBL] [Abstract][Full Text] [Related]
11. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report. Tanaka H; Matsuda R; Nakamura M; Nakagawa I; Nakase H Anticancer Res; 2022 Aug; 42(8):3975-3979. PubMed ID: 35896237 [TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Allen UD; Preiksaitis JK; Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381 [TBL] [Abstract][Full Text] [Related]
16. Management and outcome of liver recipients with post-transplant lymphoproliferative disease. Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611 [TBL] [Abstract][Full Text] [Related]
17. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB; Wang Y; Song QJ; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic study of post-transplant lymphoproliferative disorders]. Zhang YN; Zhou XG; Wang CZ; Wei P; Zhang SH; Zheng YY Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):209-12. PubMed ID: 16776977 [TBL] [Abstract][Full Text] [Related]